These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 15833005)

  • 1. [Means of purification of cephalexin with a view to therapeutic use].
    Stan C; Dumitrache M; Diaconu DE
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(3):718-20. PubMed ID: 15833005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronopharmacological study of cephalexin in dogs.
    Prados AP; Ambros L; Montoya L; Rebuelto M
    Chronobiol Int; 2007; 24(1):161-70. PubMed ID: 17364586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A simple disk diffusion test to identify beta-lactamase-negative, ampicillin-resistant Haemophilus influenzae--application of cephalexin, cefsulodin and cefaclor disks].
    Endo R; Yamane N; Tamayose MH; Uchibori KK; Nakasone I
    Rinsho Byori; 2010 Oct; 58(10):963-71. PubMed ID: 21077285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antimicrobial activities of some new tetrahydro-2H-1,3,5-thiadiazine-2-thione derivatives of cephalexin.
    Balkan A; Ertan M; Sarac S; Yuluğ N
    Arzneimittelforschung; 1990 Nov; 40(11):1246-9. PubMed ID: 2085339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of cephalexin from two oral formulations in dogs].
    Ehinger AM; Kietzmann M
    Berl Munch Tierarztl Wochenschr; 2002; 115(1-2):57-61. PubMed ID: 11852685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metoclopramide modifies oral cephalexin pharmacokinetics in dogs.
    Prados AP; Kreil V; Albarellos G; Waxman S; Rebuelto M
    J Vet Pharmacol Ther; 2007 Apr; 30(2):127-31. PubMed ID: 17348897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional expression of stereoselective metabolism of cephalexin by exogenous transfection of oligopeptide transporter PEPT1.
    Mitsuoka K; Kato Y; Kubo Y; Tsuji A
    Drug Metab Dispos; 2007 Mar; 35(3):356-62. PubMed ID: 17142565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral cephalexin for acne vulgaris: clinical experience with 93 patients.
    Fenner JA; Wiss K; Levin NA
    Pediatr Dermatol; 2008; 25(2):179-83. PubMed ID: 18429774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 7-(Alpha-aminophenylacetamido)-3-azidomethyl-3-cephem-4-carboxylic acid.
    Willner D; Holdrege CT; Baker SR; Cheney LC
    J Antibiot (Tokyo); 1972 Jan; 25(1):64-7. PubMed ID: 5013325
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics and tissue fluid distribution of cephalexin in the horse after oral and i.v. administration.
    Davis JL; Salmon JH; Papich MG
    J Vet Pharmacol Ther; 2005 Oct; 28(5):425-31. PubMed ID: 16207304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of cephalexin monohydrate suspension in polypropylene oral syringes.
    Sylvestri MF; Makoid MC; Cox BE
    Am J Hosp Pharm; 1988 Jun; 45(6):1353-6. PubMed ID: 3414705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on the transfer of cefroxadine to human tears].
    Hara J; Tanaka Y; Harino S; Deguchi K
    Jpn J Antibiot; 1985 Feb; 38(2):230-4. PubMed ID: 4009946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antibacterial activity of some ureido cephalexin and cefadroxil derivatives.
    Valcavi U; Brandt A; Corsi GB; Innocenti S; Minoja F; Pascucci G
    Farmaco Sci; 1980 Jul; 35(7):563-72. PubMed ID: 7450045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical properties of loracarbef: the remarkable solution stability of an oral 1-carba-1-dethiacephalosporin antibiotic.
    Pasini CE; Indelicato JM
    Pharm Res; 1992 Feb; 9(2):250-4. PubMed ID: 1553350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereospecific absorption and degradation of cephalexin.
    Tamai I; Ling HY; Timbul SM; Nishikido J; Tsuji A
    J Pharm Pharmacol; 1988 May; 40(5):320-4. PubMed ID: 2899625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-Deacetoxy-7-(alpha-amino-1-cyclohexenylacetamido) cephalosporanic acid (SCE-100), a new semisynthetic cephalosporin. III. Comparative studies on absorption, distribution and excretion of SCE-100 and cephalexin (CEX) in laboratory animals.
    Yamazaki T; Tsuchiya K
    J Antibiot (Tokyo); 1976 May; 29(5):571-8. PubMed ID: 956046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of aqueous two-phase systems for in situ extraction of water soluble antibiotics during their synthesis by enzymes immobilized on porous supports.
    Hernandez-Justiz O; Fernandez-Lafuente R; Terreni M; Guisan JM
    Biotechnol Bioeng; 1998 Jul; 59(1):73-9. PubMed ID: 10099316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical properties of amphoteric beta-lactam antibiotics. II: Solubility and dissolution behavior of aminocephalosporins as a function of pH.
    Tsuji A; Nakashima E; Yamana T
    J Pharm Sci; 1979 Mar; 68(3):308-11. PubMed ID: 34022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biopharmaceutical aspects of the medicinal forms of cephalexin].
    Garsheva GB; Berezovskaia LN; Grakovskaia LK
    Antibiot Med Biotekhnol; 1987 Nov; 32(11):844-6. PubMed ID: 3439790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of degradation of cefazolin and cephalexin in aqueous solution.
    Rattie ES; Guttman DE; Ravin LJ
    Arzneimittelforschung; 1978; 28(6):944-8. PubMed ID: 35181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.